Tamsulosin hydrochloride and Rash macular - a phase IV clinical study of FDA data


Rash macular is found among people who take Tamsulosin hydrochloride, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Tamsulosin hydrochloride and have Rash macular. It is created by eHealthMe based on reports of 12,289 people who have side effects when taking Tamsulosin hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

12,289 people reported to have side effects when taking Tamsulosin hydrochloride.
Among them, 34 people (0.28%) have Rash macular.

What is Tamsulosin hydrochloride?

Tamsulosin hydrochloride has active ingredients of tamsulosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 12,702 Tamsulosin hydrochloride users for its effectiveness, alternative drugs and more.

What is Rash macular?

Rash macular (small, flat red spots) is found to be associated with 2,178 drugs and 1,473 conditions by eHealthMe.

Number of Tamsulosin hydrochloride and Rash macular reports submitted per year:

Could Tamsulosin hydrochloride cause Rash macular?

Time on Tamsulosin hydrochloride when people have Rash macular *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Rash macular when taking Tamsulosin hydrochloride *:

  • female: 3.12 %
  • male: 96.88 %

Age of people who have Rash macular when taking Tamsulosin hydrochloride *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 3.45 %
  • 50-59: 0.0 %
  • 60+: 96.55 %

Common drugs people take besides Tamsulosin hydrochloride *:

  1. Imbruvica: 4 people, 11.76%
  2. Amlodipine: 4 people, 11.76%
  3. Pantoprazole: 3 people, 8.82%
  4. Pentasa: 3 people, 8.82%
  5. Wellbutrin: 3 people, 8.82%
  6. Furosemide: 3 people, 8.82%
  7. Vesicare: 3 people, 8.82%
  8. Olive Oil: 3 people, 8.82%
  9. Aricept: 3 people, 8.82%
  10. Sinemet: 3 people, 8.82%

Common side effects people have besides Rash macular *:

  1. Rashes (redness): 13 people, 38.24%
  2. Face Oedema (swelling of face): 6 people, 17.65%
  3. Penile Swelling: 6 people, 17.65%
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 6 people, 17.65%
  5. Skin Exfoliation (removal of the oldest dead skin cells): 6 people, 17.65%
  6. Fatigue (feeling of tiredness): 6 people, 17.65%
  7. Itching: 5 people, 14.71%
  8. Constipation: 4 people, 11.76%
  9. Nausea (feeling of having an urge to vomit): 4 people, 11.76%
  10. White Blood Cell Count Decreased: 4 people, 11.76%

Common conditions people have *:

  1. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 4 people, 11.76%
  2. Parkinson's Disease: 3 people, 8.82%
  3. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 8.82%
  4. Malaise (a feeling of general discomfort or uneasiness): 3 people, 8.82%
  5. Stress And Anxiety: 3 people, 8.82%
  6. Biliary Sepsis: 2 people, 5.88%
  7. International Normalised Ratio Increased: 2 people, 5.88%
  8. Urinary Tract Infection: 1 person, 2.94%
  9. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 2.94%
  10. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Tamsulosin hydrochloride and have Rash macular?

Check whether Rash macular is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Rash macular and when was it recovered:

Expand to all the drugs that have ingredients of tamsulosin hydrochloride:

Alternative drugs to, pros and cons of Tamsulosin hydrochloride:

Common Tamsulosin hydrochloride side effects:

Browse all side effects of Tamsulosin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Rash macular treatments and more:

COVID vaccines that are related to Rash macular:

Common drugs associated with Rash macular:

All the drugs that are associated with Rash macular:

Common conditions associated with Rash macular:

All the conditions that are associated with Rash macular:

How the study uses the data?

The study uses data from the FDA. It is based on tamsulosin hydrochloride (the active ingredients of Tamsulosin hydrochloride) and Tamsulosin hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: